Analytical Data
-
Gene name
TKL4
- Application
-
Alternative Names
TKL4；
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
A0A1Y3DN75
-
Expression Region
全长
-
AA Sequence
full
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The TKL4 recombinant protein is a subject of intense research due to its significant role in various biological processes and potential therapeutic applications. TKL4, or TKL4-like kinase, is part of the tyrosine kinase family, which is crucial for regulating cell signaling pathways involved in growth, differentiation, and metabolism. Studies have indicated that TKL4 may play a pivotal role in cellular responses to stress and survival mechanisms. Its expression levels have been correlated with various conditions, including cancer, making it a potential biomarker for disease progression. Furthermore, the ability to produce TKL4 as a recombinant protein has opened avenues for studying its functional properties and interactions at a molecular level. Researchers are focusing on elucidating its structure-function relationship, understanding its regulatory mechanisms, and exploring its interactions with other proteins. This knowledge is essential for developing targeted therapies aimed at modulating the activity of TKL4 in pathological states. Overall, the investigation of TKL4 recombinant protein encompasses a multidisciplinary approach, integrating molecular biology, biochemistry, and therapeutic development, to harness its potential in advancing our understanding of cellular dynamics and improving clinical outcomes.
